Taxane Induced Peripheral Neuropathy in Chinese Patients With Breast Cancer

Last updated: March 26, 2020
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Overall Status: Active - Recruiting

Phase

N/A

Condition

Breast Cancer

Cancer

Neurologic Disorders

Treatment

N/A

Clinical Study ID

NCT04068090
TIPN in China
  • Ages > 16
  • Female
  • Accepts Healthy Volunteers

Study Summary

The purpose of this study is to collect clinical data, blood samples, and self reported symptoms of peripheral neuropathy from Chinese patients with breast cancer after treatment with taxanes. This data will be used to develop predictive markers for neuropathy.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Diagnosis of breast cancer

  • Females aged 16 and older

  • Planning to receive or previous treated with taxanes

Exclusion

Exclusion Criteria:

  • Poorly controlled or insulin-dependent diabetes or other condition likely topredispose to neurotoxicity

Study Design

Total Participants: 500
Study Start date:
August 23, 2019
Estimated Completion Date:
December 31, 2020

Connect with a study center

  • Cancer Hospital, Chinese Academy of Medical Sciences

    Beijing, Beijing 100021
    China

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.